[-] Show simple item record

dc.contributor.authorRugge, J. Bruineng
dc.contributor.authorLochner, Jennifer E.eng
dc.contributor.authorJudkins, Dolores Zegareng
dc.date.issued2006eng
dc.description.abstractScreening patients with chronic hepatitis B infection (HBsAg+) for hepatocellular carcinoma by alpha-fetoprotein (AFP) or by AFP plus ultrasound (AFP/US) detects hepatocellular carcinoma tumors at earlier stages and increases resection rates (strength of recommendation [SOR]: B, based on a systematic review of fair-quality randomized controlled trials). It is unclear whether screening with AFP or AFP/US improves disease-specific or all-cause mortality (SOR: B).eng
dc.identifier.urihttp://hdl.handle.net/10355/3573eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2006 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 55, no. 02 (February 2006)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectultrasoundeng
dc.subjectresection rateseng
dc.subjectalpha-fetoprotein (AFP)eng
dc.subjectserum markerseng
dc.subject.lcshLiver -- Cancereng
dc.subject.lcshhepatitis Beng
dc.subject.lcshalpha-fetoproteineng
dc.subject.meshCarcinoma, Hepatocellulareng
dc.titleWhat is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record